RW4-52789-29656
4 vaccinations
3 coded responses
34 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 606 / IL
- Registered
- 2020-12-20
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-20
Registered in v-safe
-
2020-12-20
Dose 1 — Pfizer-BioNTech
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-29
- 2021-01-03
-
2021-01-06
Dose 2 — Pfizer-BioNTech
- 2021-01-06
-
2021-01-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-07
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-15
- 2021-01-22
- 2021-01-27
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-04-07
- 2021-07-07
-
2021-09-28
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-10-01
- 2021-10-02
- 2021-10-04
- 2021-10-07
- 2021-10-12
- 2021-10-19
- 2021-10-26
- 2021-12-28
- 2022-03-29
-
2022-09-08
Dose 4 — Moderna
- 2022-09-13
-
2022-09-22
Survey response — day 14, dose 4MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend schoolFree text: ColdMedDRA releases: 2024-11 · check-in free text available
-
2022-09-29
Survey response — day 21, dose 4MedDRA: Urinary tract infection — Feeling: Good · Be unable to work or attend schoolFree text: UTIMedDRA releases: 2024-11 · check-in free text available
- 2022-10-20
-
2022-12-10
Survey response — 3 months, dose 4MedDRA: Hyperemesis gravidarum — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Hyperemesis gravidarumMedDRA releases: 2024-11 · check-in free text available
-
2022-12-10
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-12-12
- 2023-03-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-20 | Pfizer-BioNTech | |
| 2 | 2021-01-06 | Pfizer-BioNTech | |
| 3 | 2021-09-28 | Pfizer-BioNTech | Flu |
| 4 | 2022-09-08 | Moderna | No |
Call center
2 call center cases
1 unsuccessful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 12 — day 14, dose 4
Symptoms: Cold
Release 12 — day 21, dose 4
Symptoms: UTI
Release 12 — 3 months, dose 4
Symptoms: Hyperemesis gravidarum
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Hyperemesis gravidarum | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Urinary tract infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release